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Introduction The fluoroquinolones are considered relatively 
safe and well tolerated as indicated by earlier reports  In  the  modern  intensive  poultry  production, 
which demonstrated that enrofloxacin is well tolerated  antimicrobial agents are being increasingly used to 
at the recommended dosage in cats [8, 9, 10]. However,  enhance  feed  efficiency,  promote  health,  improve 
it  has  been  reported  that  fluoroquinolones  are  also  productivity, and are also used for disease prophylaxis 
associated  with  a  low  incidence  of  adverse  effects  and treatment [1, 2]. In this context, it is important to 
related to gastrointestinal, skin, hepatic, central nervous  note  that  the  fluoroquinolones  are  synthetic  anti-
system functions, and phototoxicity [11]. Further, there  microbial agents used extensively in the poultry industry 
is evidence to show that enrofloxacin administration in  for  the  control  of  premature  mortality  and  for  the 
broiler chickens resulted in a significant decline in the  prophylaxis and treatment of respiratory, renal, and 
lymphocyte count [12] and reduction in haemagglu- digestive infections [3,4]. Enrofloxacin is a fluoro-
tination inhibition (HI) titre and associated histopatho- quinolone that was developed exclusively for veterinary 
logical changes in the lymphoid organs [13].  use  and  is  currently  used  in  large-scale  in  poultry, 
Data  on  the  safety  regarding  repeated  oral  especially  for  the  treatment  of  chronic  respiratory 
administration of fluoroquinolones in poultry are very  disease, colibacillosis, salmonellosis and fowl cholera 
scarce  [14].  Information  on  the  residual  effects  of  [5,6]. In vivo, enrofloxacin is metabolised into pharma-
enrofloxacin and post market surveillance on serum  cologically  active  metabolite  ciprofloxacin  by  liver 
biochemical  parameters,  histopathological  and  ultra  microsomal enzymes that belong to the cytochrome P450 
structural changes in broiler chickens during the post  family [4,7].
treatment periods is lacking.  
Hence, we conducted a pharmacological study  in 
broiler chickens to assess the safety and adverse effects 
of enrofloxacin administration on serum biochemical 
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Abstract
Aim: A pharmacological study was undertaken to evaluate the safety and adverse effects of enrofloxacin administration in 
broiler chickens by assessing the serum biochemical parameters, associated histopathological and ultra structural changes in 
liver and kidney.
Materials and Methods:  Birds in the treatment group were administered with enrofloxacin at the recommended therapeutic 
dose 10mg/kg body weight via drinking water for five successive days, while the control group (untreated group) received non 
medicated water. Serum biochemical parameters viz., total protein, albumin, lactate dehydrogenase, alkaline phosphatase, 
creatine kinase, lipase, triglyceride, gamma glutamyl transferase, urea, uric acid and creatinine were estimated at 24hour and 
48hour intervals during the dosing and withdrawal periods, respectively. Liver and kidney tissue samples collected from 1, 3, 
5, 7, and 9 days post treatment groups were subjected to histopathological and ultrastructural examinations.
Results: There was no significant change (p>0.05) in total protein, albumin, lactate dehydrogenase, alkaline phosphatase, 
creatine kinase, lipase, triglyceride and urea levels in the enrofloxacin administered broiler chickens at all the time points 
evaluated. However, a significant increase (p<0.05) in gamma glutamyl transferase, uric acid and creatinine levels were 
th observed after the 4  dose of the enrofloxacin and on day 1 post treatment. During the withdrawal period, the elevated levels 
declined gradually and showed the trend towards control values as evidenced by a statistically insignificant difference on 3, 5, 
7 and 9 days post treatment when compared to that of control group. These biochemical changes were substantiated by 
histopathological and ultrastructural changes elicited in liver and kidney.
Conclusion:  The  reversible  trend  observed  in  serum  biochemical  parameters,  histopathological  and  ultra  structural 
alterations in liver and kidney during the withdrawal period suggests that enrofloxacin is safe if administered to broiler 
chickens at the recommended therapeutic dose and if the stipulated withdrawal period is strictly adhered to.
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parameters, and to thoroughly evaluate the associated  collected from the wing vein at 24 hour interval during 
histopathological and ultrastructural alterations in liver  the dosing period and at 48 hour interval during the 
and kidney. withdrawal period up to 9 days post treatment. Serum 
samples thus obtained were subjected to total protein,  Materials and Methods
albumin,  lactate  dehydrogenase  (LDH),  alkaline 
Ethical approval: Institutional Animal Ethics Committee  phosphatase  (ALP),  creatine  kinase  (CK),  lipase, 
(IAEC), Madras Veterinary College, TANUVAS has  triglyceride, gamma glutamyl transferase (GGT), urea, 
accorded  permission  for  conducting  this  biological  uric acid and creatinine estimation by auto analyzer   
trial. (A-15, Bio-Systems) using standard kits. Statistical 
analysis was carried out by following One way analysis 
Medication  with  enrofloxacin  containing  water: 36 
of variance as described by Snedecor and Cochran [17]. day old broiler chicks (Broiler strain B ) acquired from  1
Institute  of  Poultry  Production  and  Management  Histopathology:  Treatment  groups  were  sacrificed 
(IPPM),  TANUVAS,  Chennai-51  were  randomly  ethically on 1, 3, 5, 7 and 9 days post treatment and 
divided into control and treatment groups and were  control birds were sacrificed on day 9 post treatment. 
maintained  under  standard  management  conditions.  Liver and kidney tissue samples were collected in 10% 
Control group (I) received non medicated water while  formalin  and  were  subjected  to  histopathological 
the  treatment  groups  (II,  III,  IV,  V  and  VI)  were  examination [18].
administered  with  enrofloxacin  at  recommended 
Ultrastructural study: Liver and kidney tissue samples  therapeutic dose of 10mg/kg body weight, via drinking 
from control and treatment groups (day 1 and day 9  water for five successive days from 43rd to 47th day of 
post  treatments)  were  collected  immediately  after  age [13, 15]. The pulsed water medication was given as 
sacrificing the birds and processed. Tissue sections  per the methods described by Charleston et al. [16]. 
were  examined  under  a  transmission  electron  Birds received their freshly-prepared daily medication 
microscope (Philips 2010, Netherlands) operated at  during a 4 hour period in the morning, and their water 
60KVA and photographed [18]. was antibiotic free for the remaining 20 hours in each 
day. The concentration of enrofloxacin in the water, to  Results
administer the required dose per kg of body weight, 
Serum biochemical parameters: It is discernible from  was calculated by determining the water consumption  our  results  that  there  was  no  significant    change  and body weight of each bird on the day of medication. (p>0.05) in total protein, albumin, LDH, ALP, CK, 
Serum biochemical parameters: Blood samples were  lipase,  triglyceride  and  urea  levels  in  enrofloxacin 
Table-1. Effect of enrofloxacin administration (10mg/kg body weight, in drinking water for 5 successive days) on total 
protein, albumin, lactate dehydrogenase, alkaline phosphatase, creatine kinase, lipase and triglyceride levels (data is shown 
as Mean±SE, n=6)
TP (g/dL) Albumin (g/dL) LD (U/L) AP (U/L) CK (U/L) Lipase (U/L) TG (mg/dL)
Control 2.88±0.13 1.59±0.06 1826.18±143.19 1351.30±86.91 1014.50±71.27 21.34±1.31 87.42±5.90
After 1st dose 3.01±0.04 1.50±0.01 1852.50±131.90 1249.35±44.61 1026.50±32.72 20.36±1.13 91.25±5.53
2nd dose 3.14±0.07 1.59±0.05 1933.18±159.53 1414.07±71.22 1027.83±35.24 23.67±1.79 95.60±4.98
3rd dose 3.03±0.06 1.66±0.04 1869.08±101.64 1510.78±57.48 1041.50±35.17 25.27±2.51 92.22±6.75
4th dose 2.94±0.14 1.51±0.08 2014.80±095.23 1358.47±86.64 1107.00±54.64 22.99±2.33 98.35±6.36
Post treatment
Day 1 3.20±0.23 1.70±0.10 1918.37±192.28 1379.10±64.96 1118.33±27.09 26.67±1.36 106.63±8.38
Day 3 2.99±0.07 1.65±0.06 1985.72±103.05 1424.35±84.83 1060.50±33.56 24.79±1.60 106.10±4.75
Day 5 3.13±0.07 1.64±0.04 1966.23±166.54 1503.07±53.04 1000.33±55.94 25.62±1.84 101.23±3.13
Day 7 2.95±0.21 1.51±0.07 1871.40±160.28 1439.40±86.04 1021.00±51.46 25.66±2.06 97.97±8.39
Day 9 2.82±0.04 1.55±0.04 1830.00±131.12 1456.43±70.82 1010.17±24.39 20.34±1.30 95.60±1.42
TP : Total protein, LD: Lacto dehydrogenase, AP: Alkaline phosphatase, CK: Creatinine kinase, TG: Triglyceride
Table-2. Effect of enrofloxacin administration (10mg/kg body weight, in drinking water for 5 successive days) on gamma 
glutamyl transferase, urea, uric acid and creatinine levels (data is shown as Mean±SE, n=6)
Gamma glutamyl transferase(U/L) Urea  (mg/dL) Uric acid  (mg/dL) Creatinine  (mg/dL)
c Control 21.53 ±2.28 3.38±0.31 4.86 ±0.57 0.42 ±0.01
c c c After 1st dose 20.90 ±0.49 3.25±0.18 5.26 ±0.38 0.41 ±0.01
abc bc bc 2nd dose 25.20 ±0.89 3.40±0.36 5.66 ±0.00 0.43 ±0.02
abc abc c 3rd dose 26.35 ±5.67 4.02±0.36 6.10 ±0.21 0.42 ±0.02
a ab ab 4th dose 33.31 ±4.82 3.97±0.19 6.78 ±0.16 0.48 ±0.03
Post treatment 
ab a a Day 1 32.47 ±0.71 4.13±0.29 7.27 ±1.06 0.52 ±0.03
abc abc bc Day 3 28.85 ±1.69 3.90±0.34 5.89 ±0.74 0.46 ±0.01
abc c bc Day 5 25.83 ±0.99 4.03±0.19 5.11 ±0.36 0.45 ±0.02
c bc bc Day 7 23.40 ±1.12 3.30±0.09 5.53 ±0.21 0.44 ±0.03
c bc bc Day 9 23.93 ±4.08 3.43±0.12 5.50 ±0.36 0.45 ±0.03
c c
Means bearing different superscripts (a,b,c) within the column differ significantly (p<0.05)Available at www.veterinaryworld.org/Vol.6/Sept-2013/17.pdf
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administered broiler chickens at all the time points  on day 1 post treatment, hepatocytes showed atrophied 
evaluated (Table-1). However, a significant increase  nucleus,  cytoplasm  was  vacuolated  with  scattered 
(p<0.05) in GGT, uric acid and creatinine levels were  cytoplasmic  organelles  and  swollen  mitochondria 
th (Fig-7).  While,  in  9  day  post  treatment  group  observed after the 4  dose of the enrofloxacin and on 
hepatocytes showed normal nucleus but few cells had  day  1  post  treatment.  The  elevated  levels  declined 
shrunken  nucleus.  Mitochondrial  swelling  was  the  gradually during the withdrawal period as evidenced 
only appreciable lesion observed in few cases (Fig-8). by a statistically insignificant change starting from day 
3 post treatment (Table-2).
Histopathology of the kidney: Control group showed 
Histopathology and ultra structural study normal features of kidney (Fig-9). Kidney from day 1 
Histopathology  of  the  liver: Liver of control group  post  treatment  group  revealed  degeneration  and 
revealed no histological aberrations (Fig-1). On the  necrosis  of  tubular  epithelial  cells  with  granular 
other hand, on day 1 post treatment, hepatocytes were  eosinophilic  cytoplasm  (Fig-10).  On  day  3  post 
swollen  and  showed  vacuolated  cytoplasm.  treatment, degeneration of tubular epithelial cells with 
Degeneration of hepatocytes and areas of congestion  haemorrhagic areas were noticed. However, in few 
were also observed (Fig-2). Whereas, on day 3 post  cases, cytoplasm of swollen tubular epithelial cells was 
treatment  no  sinusoidal  space  could  be  observed  filled with eosinophilic material (Fig-11). Degeneration 
indicating that hepatocytes were highly swollen and  of tubular epithelium persisted in day 5 post treatment 
also exhibited few areas of vacuolar degeneration with  group; however it was only mild and was also observed 
vacuolated cytoplasm (Fig-3). However, on day 5 post  in  only  few  cases  (Fig-12).  Indeed,  mild  swollen 
treatment sinusoidal spaces reemerged and samples  tubular  epithelial  cells  were  the  only  appreciable 
from only a few birds showed focal areas of infiltrated  lesions observed on day 7 and 9 post treatment (Fig-
inflammatory  cells  (Fig-4).  Mild  vacuolation  of  13).
hepatocytes was the only appreciable lesion noticed on 
Ultrastructural changes in the kidney: Control group  day 9 post treatment (Fig-5).
revealed normal glomeruli and tubular epithelial cells 
Ultrastructural  changes  in  the  liver: Control group  with unaltered brush border (Fig-14). In 1 day post 
showed normal hepatocyte morphology pertaining to  treatment group, normal architecture of glomeruli and 
organelles  such  as  nucleus,  mitochondria  and  tubular epithelial cells vanished. Prominent features of 
endoplasmic reticulum (Fig-6). In the treatment group,  the  tubular  epithelium  include  shrunken  nucleus, 
Figure-1. Liver of control group 
showing normal architecture. 
H & E, x10.
Figure-2.  Liver  of  1  day  post 
treatment group showing degene-
ration of hepatocytes and areas of 
congestion. H&E, x10.
rd Figure-3.  Liver  of  3   day  post 
treatment  group  showing  no 
sinusoidal  spaces  indicating 
swollen  hepatocytes  and  few 
areas  of  vacuolar  degeneration. 
H&E, x20.
th Figure-4.  Liver  of  5   day  post 
treatment  chicken  showing  focal 
areas  of  infiltrated  inflammatory 
cells. H&E, x20.
th Figure-5.  Liver  of  9   day  post 
treatment  group  showing  mild 
vacuolation  of  hepatocytes.       
H&E, x10.
Figure-6. Liver of control group, 
normal hepatocytes with nucleus 
and mitochondria. Uranyl acetate 
& Reynold's solution, x10000.
Figure-7.  Liver  of  day  1  post 
treatment group showing hepato-
cytes  with  atrophied  nucleus, 
vacuolated cytoplasm and swollen 
mitochondria.  Uranyl  acetate  & 
Reynold's solution, x10000.
th Figure-8.  Liver  of  9   day  post 
treatment group with hepatocytes 
showing  mitochondrial  swelling. 
Uranyl  acetate  &  Reynold's 
solution, x10000.Available at www.veterinaryworld.org/Vol.6/Sept-2013/17.pdf
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swollen  mitochondria,  vacuolated  cytoplasm  and  recommended  dose  of  5  mg/kg  IM,  once  daily  to 
attrition  of  brush  border  (Fig-15).  However,  mild  healthy dogs for 14 days, caused transient increases in 
vacuolation in cytoplasm and swollen mitochondria  AST  and  mean  corpuscular  volume  levels.  Similar 
were the only considerable lesions found in the 9 day  effects are reported in humans receiving ciprofloxacin 
post treatment group (Fig-16). and norfloxacin [22, 23].
Serum GGT is a highly specific and indicative  Discussion
enzyme  for  liver  function  and  more  sensitive  than 
In  the  present  study,  the  serum  biochemical  transaminases (AST and ALT) and ALP. A significant 
parameters  revealed  insignificant  changes  in  total  elevation in serum GGT level was observed after the 
protein, albumin, LDH, ALP, CK, lipase, triglyceride  4th dose of enrofloxacin administration and on day 1 
and urea levels in enrofloxacin administered broiler  post  treatment  GGT  levels  showed  a  tendency  to 
chickens at all the time points evaluated. This finding is  decline gradually during the withdrawal period. These 
in accordance with Elkholy et al. [19], who showed that  findings were supported by Ellakany et al. [24] who 
administration of Enrotryl® and Baytril® at a dose  also  reported  a  similar  trend  that  enrofloxacin  at 
equivalent to 10 mg enrofloxacin base/kg body weight  100mg/kg  body  weight  in  broiler  chicken  for  5 
daily for five successive days, to laying hens induced  consecutive days caused elevation of serum ALT, but 6 
insignificant changes in serum glucose, cholesterol,  days after the withdrawal the values returned to the 
creatinine  levels,  serum  alanine  amino  transferase  control levels. Similarly, the authors further reported 
(ALT), aspartate amino transferase (AST) and ALP  that serum AST level was found to be higher than the 
activities. control group, albeit not significant, in those receiving 
However,  Moustafa  et  al.  [20]  reported  that  100mg/kg  body  weight  or  10mg/kg  body  weight 
administration of enrofloxacin in high doses (100, 200  enrofloxacin, then decreased after withdrawal of the 
and 400 ppm through drinking water) for long periods  drug.
(6 weeks) was accompanied with adverse effects on  In the present study, the elevated levels of GGT 
different organs along with elevated levels of AST,  can be correlated with the histopathological changes in 
ALT, ALP, urea, uric acid and creatinine, hypopro- the liver observed during the withdrawal period. For 
teinaemia and hypoalbuminaemia. In addition, Tras et  example, on day 1 post treatment hepatocytes were 
al.  [21]  showed  that  enrofloxacin  injection  at  the  swollen, degenerated with vacuolated cytoplasm and 
Figure-9. Kidney of control group 
showing  normal  glomeruli  and 
tubular epithelial cells. H&E, x10.
Figure-10. Kidney of 1 day post 
treatment  group  showing 
degeneration  and  necrosis  of 
tubular  epithelial  cells  with 
granular  eosinophilic  cytoplasm. 
H&E, x20.
rd Figure-11. Kidney of 3  day post 
treatment  group  showing 
degeneration of tubular epithelial 
cells  with  haemorrhagic  areas. 
H&E, x20.
th Figure-12. Kidney of 5  day post 
treatment  chicken  showing  mild 
tubular degeneration. H&E, x20.
th Figure-13. Kidney of 9  day post 
treatment  group  showing  mild 
tubular  degenerative  changes. 
H&E, x10.
Figure-14.  Kidney  of  control 
group  showing  normal  tubular 
epithelial  cells  with  unaltered 
brush  border.  Uranyl  acetate  & 
Reynold's solution, x10000.
Figure-15. Kidney of day 1 post 
treatment group showing tubular 
epithelium with shrunken nucleus, 
balonised mitochondria, vacuolated 
cytoplasm  and  attrition  of  brush 
border. Uranyl acetate & Reynold's 
solution, x10000.
th Figure-.16. Kidney of 9  day post 
treatment group showing tubular 
epithelial  cells  with  normal 
nucleus,  brush  border,  but  with 
mild  mitochondrial  swelling. 
Uranyl  acetate  &  Reynold's 
solution, x10000.Available at www.veterinaryworld.org/Vol.6/Sept-2013/17.pdf
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Conclusion showed  areas  of  congestion. Vacuolar  degeneration 
rd was  persistent  till  3   day  post  treatment,  however,  Enrofloxacin  administration  at  recommended 
during the subsequent withdrawal period the lesions  therapeutic dose caused insignificant changes in total 
were mild as indicated by clear sinusoidal spaces and  protein, albumin, LDH, ALP, CK, lipase, triglycerides 
focal areas of infiltrated inflammatory cells with only a  and urea levels. A significant but transient elevation in 
mild vacuolation of hepatocytes. These observations  GGT, uric acid and creatinine was noticed and these 
are in conformity with Ellakany et al. [24]. Further,  biochemical alterations were suggestive of histopatho-
Shawky  et  al.  [25]  also  showed  that  enrofloxacin  logical and ultrastructural changes observed in liver 
administered  at  400  ppm  for  6  weeks  produced  and kidney. The restoration towards the control values 
histopathological changes in liver. Vaccaro et al. [26]  of biochemical parameters accompanied by reversal of 
opined that the major cause of enrofloxacin-induced  histopathological and ultra structural lesions towards 
hepato toxicity can be attributed to the inhibition of  normal contour during the withdrawal period clearly 
hepatic  cytochrome  P450  enzymes  which  are  suggests  that  enrofloxacin  is  extremely  safe  if 
responsible for drug metabolism. administered at recommended therapeutic dose and if 
Hepatocellular injury represented by significant  the stipulated withdrawal period is strictly followed.   
elevations in the serum GGT activities was further  Adhering  to  these  precautions  can  prevents  any 
ascertained by the electron microscopic examination of  adverse drug reactions and untoward residual effects.
liver samples of broiler chickens administered with 
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